Phenylpiperidine derivative
    1.
    发明授权
    Phenylpiperidine derivative 失效
    苯基哌啶衍生物

    公开(公告)号:US06150355A

    公开(公告)日:2000-11-21

    申请号:US43154

    申请日:1998-03-13

    摘要: A phenylpiperidine derivative or pharmaceutical acceptable salt thereof represented by formula (I): ##STR1## wherein X represents CH or N; Y--Z represents CH.sub.2 --O, CH.sub.2 --S, CH.sub.2 --CH.sub.2, CH.dbd.CH or CONR.sup.5 (wherein R.sup.5 represents hydrogen or lower alkyl); R.sup.1 represents hydrogen, lower alkyl, halogen, lower alkoxy or trifluoromethyl; and R.sup.2, R.sup.3 and R.sup.4 are the same or different and each represents hydrogen, lower alkyl or QR.sup.6 (wherein Q represents a single bond or lower alkylene, and R.sup.6 represents hydroxy, lower alkoxyalkoxy, lower alkoxy, lower alkylthio, nitro, halogen, lower alkanoyloxy, lower alkoxycarbonyl, lower alkanoyl or carboxyl).The present invention provides novel phenylpiperidine derivatives useful as analgesics.

    摘要翻译: PCT No.PCT / JP96 / 02589 Sec。 371日期1998年3月13日 102(e)1998年3月13日PCT PCT 1996年9月11日PCT公布。 公开号WO97 / 10213 日期:1997年3月20日由式(I)表示的苯基哌啶衍生物或其药学上可接受的盐:其中X表示CH或N; Y-Z表示CH 2 -O,CH 2 -S,CH 2 -CH 2,CH = CH或CONR 5(其中R 5表示氢或低级烷基)。 R 1表示氢,低级烷基,卤素,低级烷氧基或三氟甲基; 并且R 2,R 3和R 4相同或不同,各自表示氢,低级烷基或QR6(其中Q表示单键或低级亚烷基,R6表示羟基,低级烷氧基烷氧基,低级烷氧基,低级烷硫基,硝基,卤素,低级 烷酰氧基,低级烷氧基羰基,低级烷酰基或羧基)。 本发明提供了用作止痛剂的新型苯基哌啶衍生物。

    Tricyclic compounds
    2.
    发明授权
    Tricyclic compounds 失效
    三环化合物

    公开(公告)号:US06211227B1

    公开(公告)日:2001-04-03

    申请号:US09417626

    申请日:1999-10-14

    IPC分类号: A61K3138

    摘要: The present invention provides tricyclic compounds which are useful for the treatment of pollakiuria and urinary incontinence and which are represented by general formula (I): (wherein R1 represents hydrogen, substituted or unsubstituted lower alkyl, etc.; X1—X2—X3 represents CR5═CR6—CR7═CR8 (wherein R5, R6, R7 and R8, which may be the same or different, each represents hydrogen, substituted or unsubstituted lower alkyl, hydroxy, substituted or unsubstituted lower alkoxy, etc.), N(O)m═CR5—CR6═CR7 (wherein R5, R6 and R7 have the same significances as defined above, and m represents 0 or 1), S—CR7═CR8 (wherein R7 and R8 have the same significances as defined above), etc.; and when R2 represents hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkoxy, a substituted or unsubstituted N-substituted heterocyclic group, (wherein n is 0 or 1; R3 and R4, which may be the same or different, each represents hydrogen, substituted or unsubstituted lower alkyl, trifluoromethyl, etc., or R3 and R4 may be combined together to form cyclic alkyl; and Q represents hydroxy, halogen, etc.), etc., Y represents —CH2SO2—, —SCH2—, —SOCH2—, —SO2CH2—, etc.) and pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明提供可用于治疗尿频和尿失禁的三环化合物,其由通式(I)表示:其中R 1表示氢,取代或未取代的低级烷基等; X 1 -X 2 -X 3表示CR 5 = CR6-CR7 = CR8(其中R5,R6,R7和R8可以相同或不同,各自表示氢,取代或未取代的低级烷基,羟基,取代或未取代的低级烷氧基等),N(O)m = CR5-CR6 = CR7(其中R5,R6和R7具有与上述相同的含义,m表示0或1),S-CR 7 = CR 8(其中R 7和R 8具有与上述相同的含义)等 ;当R 2表示氢时,取代或未取代的低级烷基,取代或未取代的低级烷氧基,取代或未取代的N-取代的杂环基,(其中n为0或1; R 3和R 4各自可相同或不同) 代表氢,取代或未取代的低级烷基,三氟甲基 脲基甲基等,或者R 3和R 4可以组合在一起形成环烷基; 和Q表示羟基,卤素等)等,Y表示-CH 2 SO 2 - , - CH 2 - , - SOCH 2 - , - SO 2 CH 2 - 等)及其药学上可接受的盐。